![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The following is a round-up of London-listed company director and manager changes announced on Wednesday and Thursday ...
Shield Therapeutics PLC 24 July 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Unaudited Q2 2024 Trading Update ACCRUFeR® US Net Revenues of $6.9m following...
Shield Therapeutics PLC 24 July 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Directorate Change London, UK, 24 July 2024: Shield Therapeutics plc (LSE:...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...
Shield Therapeutics PLC 03 July 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Shield Enters into $5.7 million Milestone Monetization Agreement with AOP Dr...
Shield Therapeutics PLC 20 June 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Results of 2024 Annual General Meeting London, UK, 20 June 2024: Shield...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Shield Therapeutics PLC 28 May 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Shield's Korean Partner files New Drug Application for Accrufer® in the Republic of...
Shield Therapeutics PLC 10 May 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Audited results...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.475 | 30.1587301587 | 1.575 | 2.7 | 1.575 | 10881533 | 2.15071109 | DE |
4 | 0.2 | 10.8108108108 | 1.85 | 2.7 | 1.525 | 3632916 | 2.03400017 | DE |
12 | 0.4 | 24.2424242424 | 1.65 | 2.7 | 1.425 | 3336013 | 2.02679251 | DE |
26 | -4.35 | -67.96875 | 6.4 | 6.45 | 1.075 | 5097248 | 2.41872741 | DE |
52 | -7.1 | -77.5956284153 | 9.15 | 12.75 | 1.075 | 3717346 | 4.22938177 | DE |
156 | -41.95 | -95.3409090909 | 44 | 52 | 1.075 | 2085528 | 7.52416404 | DE |
260 | -126.95 | -98.4108527132 | 129 | 201 | 1.075 | 1507643 | 17.40453441 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions